![]() | ![]() |
GSK Completes Acquisition of IDRx
IDRX-42 has demonstrated activity against all clinically relevant primary and secondary KIT mutations, a key medical need in current GIST treatment.
GSK | 25/02/2025 | By Aishwarya
Muna Therapeutics Partners with GSK to Develop Novel Treatments for Alzheimer's Disease
Together, Muna and GSK will assess postmortem human brain samples with spatial transcriptomics and other approaches to identify and validate potential new drug targets.
GSK | 06/12/2024 | By Aishwarya
GSK Announces Positive Data for Arexvy (RSV) Vaccine
Arexvy is the world’s first RSV vaccine and was approved based on exceptional efficacy in adults aged 60 and older, including those who are at increased risk due to certain underlying medical conditions.
GSK | 10/10/2024 | By Aishwarya
BioVersys Extends its Strategic Collaboration with GSK
BioVersys has extended its strategic collaboration with the global biopharma company GSK to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of tuberculosis (TB).
GSK | 09/05/2024 | By Aishwarya | 192
Pharma giant GSK to build Singapore facility making Hepatitis B vaccine
Pharma giant GSK to build Singapore facility making Hepatitis B vaccine
GSK | 14/07/2023 | By Sudeep Soparkar | 299
GSK in agreement to acquire late-stage biopharma company BELLUS Health
The acquisition provides GSK access to camlipixant, a potential best-in-class and highly selective P2X3 antagonist currently in phase III development for the first-line treatment of adult patients with RCC
GSK | 25/04/2023 | By Sudeep Soparkar | 506
GSK introduces Shingrix vaccine in India
Shingrix is the world’s first non-live, recombinant subunit vaccine to be given intramuscularly in two doses
GSK | 25/04/2023 | By Sudeep Soparkar | 1154
CCI approves acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger and the share exchange steps involving the shareholders of JVCO
GSK | 15/06/2022 | By Sudeep Soparkar | 212
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy